• Home
  • Recruiting Trials

Recruiting Trials

Research Area
Study Name
Basic Eligibility
Doctors Referral
Participant Enquiry

Cardiology

Research Area:
Cardiology
Heart Failure
Study Name:
SODIUM-HF
Basic Eligibility:
Age 18 or over
Confirmed diagnosis of Heart Failure
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.

Research Area:
Cardiology
Acute Coronary Syndrome
Study Name:
AEGIS-II (CSL112_3001)
Basic Eligibility:
Type 1 Myocardial infarction
Have at least two coronary artery territories of disease > 50%
Be on treatment for Diabetes
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Middlemore Hospital.

Diabetes

Research Area:
Diabetes
Type 2 Diabetes
Study Name:
Scohia - CT19649
Basic Eligibility:
Age between 18 - 75
Diabetic Kidney Disease
Type 2 Diabetes
HbA1c less than 10.5% (≤ 91 mmol/mol)
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Gastroenterology

Research Area:
Gastroenterology
Crohn's Disease
Study Name:
RISA (M15-991)
Basic Eligibility:
Moderate to severe abdominal pain and/or daily unformed stool frequency >4
Previous biologic failure or intolerance (e.g. to infliximab or Humira)
No ileostomy/colostomy
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Haematology

Research Area:
Haematology
Follicular Lymphoma
Study Name:
FL212 (BGB-3111-212)
Basic Eligibility:
Age over 18 years
Diagnosed Follicular Lymphoma
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.

Research Area:
Haematology
Multiple Myeloma
Study Name:
KIWI
Basic Eligibility:
Age over 18
Newly diagnosed Symptomatic Multiple Myeloma
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Haematology
Myelofibrosis
Study Name:
MOMENTUM (SRA-MMB-301)
Basic Eligibility:
Age over 18
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis
Previously treaded with Ruxolitinib
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Hepatology

Research Area:
Hepatology
Fatty Liver
Study Name:
AURORA (3152-301-002)
Basic Eligibility:
Aged 18 - 75 years
Diagnosed with NASH or ‘Fatty Liver’
Do not have HIV, Cirrhosis, Hepatitis B or C
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Hepatology
Chronic Hepatitis B
Study Name:
DCR-HBVS-101, GS-US-493-5342, VIR (VIR-2218), YP (YP39364), Brii (Brii-179-001)
Basic Eligibility:
Age 18 to 65
Chronic Hepatitis B infection
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Lipidology

Research Area:
Lipidology
Hypertriglyceridemia
Study Name:
AROAPOC31001
Basic Eligibility:
Age 18 to 70
History of high triglyceride levels (>3.38 mmol/L)
BMI between 19 to 40kg/m2
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Neonatal

Research Area:
Neonatal
Neonatal care
Study Name:
ABC
Basic Eligibility:
Infants born at less than 31 weeks
Has delayed cord clamping
Non regular rhythmic breathing
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible premature infants at delivery.

Research Area:
Neonatal
Neonatal care
Study Name:
PAEAN
Basic Eligibility:
Infants born at or more than 35 weeks
Indication of perinatal depression
Moderate to severe encephalopathy
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible premature infants at delivery.

Paediatrics

Research Area:
Paediatrics
Viral Respiratory Disease
Study Name:
SHIVERS
Basic Eligibility:
Viral respiratory disease
Acute presentation to Middlemore Emergency Department or Intensive care unit
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients with acute presentation at Middlemore Hospital.

Research Area:
Paediatrics
Rheumatic Fever
Study Name:
Start
Basic Eligibility:
Aged between 5 - 14 years
Newly diagnosed with Acute rheumatic fever
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Middlemore Hospital.

Renal

Research Area:
Renal
Chronic Kidney Disease
Study Name:
Ascend ND 200808
Basic Eligibility:
Age 18 years or over
Have Chronic Kidney Disease
Needing to start on or on erythropoiesis stimulating agents (ESA) replacement therapy
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Rheumatology

Research Area:
Rheumatology
Ankylosing Spondylitis/Axial Spondyloarthritis
Study Name:
Ankylosing Spondylitis/Axial Spondyloarthritis
Basic Eligibility:
Aged 18 years or older
Diagnosis of Ankylosing Spondylitis or Axial Spondyloarthritis
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Rheumatology
Giant Cell Arthritis
Study Name:
Select - GCA (M16-852)
Basic Eligibility:
Age 50 or over
Diagnosed Giant Cell Arthritis
Headache, jaw pain, vision loss
Shoulder and/or hip pain
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Rheumatology
Systemic Lupus Erythematosus
Study Name:
Systemic Lupus Erythematosus
Basic Eligibility:
Aged 18 years or older
Diagnosis of Systemic Lupus Erythematosus
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

About Us

Middlemore Clinical Trials (MMCT) is New Zealand's largest clinical trials site, which offers world-class facilities, excellent audited procedures, and a fully integrated research unit.

Our Contacts